Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteosarcoma | 4 | 2022 | 896 | 1.790 |
Why?
|
Bone Neoplasms | 5 | 2022 | 2527 | 1.230 |
Why?
|
MicroRNAs | 7 | 2020 | 3805 | 0.970 |
Why?
|
Neoplasms, Glandular and Epithelial | 5 | 2010 | 487 | 0.700 |
Why?
|
Oligonucleotide Array Sequence Analysis | 10 | 2013 | 3777 | 0.660 |
Why?
|
RNA, Neoplasm | 5 | 2017 | 749 | 0.640 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 231 | 0.590 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.540 |
Why?
|
Ovarian Neoplasms | 9 | 2015 | 4849 | 0.500 |
Why?
|
Genomic Imprinting | 1 | 2017 | 329 | 0.500 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2014 | 0.450 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 1745 | 0.440 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2017 | 8542 | 0.440 |
Why?
|
Gene Expression Profiling | 15 | 2017 | 9417 | 0.420 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2012 | 34 | 0.400 |
Why?
|
DNA, Complementary | 2 | 2013 | 1989 | 0.380 |
Why?
|
Laryngeal Neoplasms | 1 | 2012 | 514 | 0.300 |
Why?
|
Somatomedins | 1 | 2007 | 179 | 0.280 |
Why?
|
Paraffin Embedding | 3 | 2013 | 302 | 0.280 |
Why?
|
Tissue Fixation | 3 | 2013 | 241 | 0.280 |
Why?
|
Prognosis | 13 | 2022 | 29600 | 0.280 |
Why?
|
Formaldehyde | 3 | 2013 | 357 | 0.270 |
Why?
|
Models, Genetic | 2 | 2012 | 3431 | 0.240 |
Why?
|
Chordoma | 3 | 2017 | 347 | 0.230 |
Why?
|
Databases, Genetic | 1 | 2011 | 1742 | 0.230 |
Why?
|
Survival Analysis | 5 | 2020 | 10073 | 0.220 |
Why?
|
Soybean Proteins | 1 | 2003 | 55 | 0.220 |
Why?
|
RNA, Messenger | 3 | 2020 | 12758 | 0.220 |
Why?
|
Sarcoma | 2 | 2011 | 1800 | 0.200 |
Why?
|
Bayes Theorem | 1 | 2010 | 2326 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.190 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2022 | 99 | 0.190 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3607 | 0.180 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2013 | 3634 | 0.180 |
Why?
|
Rhabdomyosarcoma | 1 | 2022 | 358 | 0.160 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1158 | 0.150 |
Why?
|
Microarray Analysis | 2 | 2013 | 748 | 0.150 |
Why?
|
Mixed Tumor, Malignant | 1 | 2017 | 16 | 0.150 |
Why?
|
Utah | 1 | 2017 | 129 | 0.140 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 145 | 0.130 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4020 | 0.130 |
Why?
|
Dietary Fats | 1 | 2003 | 1995 | 0.130 |
Why?
|
DNA Methylation | 2 | 2022 | 4391 | 0.130 |
Why?
|
Signal Transduction | 5 | 2012 | 23416 | 0.120 |
Why?
|
Mass Spectrometry | 4 | 2011 | 2189 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2017 | 1743 | 0.110 |
Why?
|
Menarche | 1 | 1997 | 532 | 0.110 |
Why?
|
Prostate-Specific Antigen | 1 | 2003 | 2465 | 0.110 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2017 | 339 | 0.110 |
Why?
|
Leiomyosarcoma | 1 | 2017 | 422 | 0.110 |
Why?
|
Aged | 19 | 2020 | 169042 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2009 | 1134 | 0.100 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2008 | 506 | 0.100 |
Why?
|
Middle Aged | 22 | 2020 | 220584 | 0.100 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3593 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12447 | 0.090 |
Why?
|
Humans | 37 | 2022 | 760617 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 12719 | 0.090 |
Why?
|
Reproducibility of Results | 9 | 2013 | 20074 | 0.090 |
Why?
|
Adult | 20 | 2020 | 220969 | 0.090 |
Why?
|
ROC Curve | 2 | 2017 | 3575 | 0.090 |
Why?
|
Cluster Analysis | 4 | 2013 | 2700 | 0.090 |
Why?
|
Body Height | 1 | 1997 | 1565 | 0.090 |
Why?
|
Cell Line, Tumor | 6 | 2017 | 16967 | 0.090 |
Why?
|
Expert Systems | 1 | 2010 | 79 | 0.090 |
Why?
|
Cohort Studies | 5 | 2020 | 41457 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2015 | 11116 | 0.080 |
Why?
|
Genes, Neoplasm | 1 | 2011 | 370 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7583 | 0.080 |
Why?
|
Databases, Nucleic Acid | 1 | 2010 | 205 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2015 | 58894 | 0.080 |
Why?
|
Female | 23 | 2020 | 392148 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2013 | 20988 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6807 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 703 | 0.080 |
Why?
|
Antigens, CD34 | 2 | 2009 | 658 | 0.080 |
Why?
|
Adenocarcinoma, Clear Cell | 2 | 2011 | 217 | 0.080 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2011 | 373 | 0.080 |
Why?
|
Granzymes | 1 | 2010 | 277 | 0.080 |
Why?
|
DNA | 1 | 2022 | 7196 | 0.080 |
Why?
|
Biopsy | 1 | 2020 | 6762 | 0.070 |
Why?
|
Protein Array Analysis | 2 | 2011 | 399 | 0.070 |
Why?
|
Cryopreservation | 1 | 2013 | 728 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2012 | 17878 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 2 | 2009 | 1394 | 0.070 |
Why?
|
Proteome | 2 | 2008 | 1857 | 0.070 |
Why?
|
Genome, Human | 2 | 2011 | 4421 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12043 | 0.070 |
Why?
|
Genes, BRCA2 | 1 | 2010 | 590 | 0.070 |
Why?
|
ras Proteins | 1 | 2012 | 1054 | 0.070 |
Why?
|
Antigens, Differentiation | 1 | 2010 | 908 | 0.070 |
Why?
|
Antigens, Nuclear | 1 | 2007 | 184 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2011 | 5304 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2010 | 753 | 0.070 |
Why?
|
Cell Division | 2 | 2015 | 4457 | 0.070 |
Why?
|
Phenotype | 3 | 2020 | 16571 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 2 | 2009 | 3394 | 0.060 |
Why?
|
Diet | 1 | 2003 | 8048 | 0.060 |
Why?
|
Glutathione Transferase | 1 | 2007 | 565 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 416 | 0.060 |
Why?
|
Adult Stem Cells | 1 | 2007 | 221 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1350 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2644 | 0.060 |
Why?
|
Metabolome | 1 | 2011 | 987 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1076 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9313 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2332 | 0.060 |
Why?
|
Proteinuria | 1 | 2007 | 606 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2017 | 64568 | 0.060 |
Why?
|
Young Adult | 3 | 2020 | 59179 | 0.060 |
Why?
|
Thymine Nucleotides | 1 | 2003 | 57 | 0.060 |
Why?
|
Proteomics | 2 | 2008 | 3836 | 0.060 |
Why?
|
Adolescent | 4 | 2020 | 88234 | 0.050 |
Why?
|
Child | 3 | 2022 | 80079 | 0.050 |
Why?
|
Carcinoma, Endometrioid | 1 | 2005 | 276 | 0.050 |
Why?
|
Male | 14 | 2020 | 360358 | 0.050 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 1703 | 0.050 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2009 | 1320 | 0.050 |
Why?
|
Carbohydrate Metabolism | 1 | 2003 | 262 | 0.050 |
Why?
|
Ovariectomy | 1 | 2004 | 613 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1149 | 0.050 |
Why?
|
Metabolomics | 1 | 2011 | 1656 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2007 | 2340 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11736 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1172 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 2 | 2007 | 3164 | 0.050 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2005 | 473 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2009 | 7847 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2872 | 0.050 |
Why?
|
Interleukin-2 | 1 | 2007 | 1887 | 0.050 |
Why?
|
RNA-Binding Protein EWS | 1 | 2022 | 210 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11106 | 0.040 |
Why?
|
Models, Statistical | 1 | 2015 | 5073 | 0.040 |
Why?
|
Computational Biology | 1 | 2012 | 3509 | 0.040 |
Why?
|
Kidney Neoplasms | 2 | 2007 | 4250 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2007 | 972 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2327 | 0.040 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 1018 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9277 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1624 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 3998 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2010 | 2722 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1610 | 0.040 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1926 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42188 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1221 | 0.030 |
Why?
|
Thigh | 1 | 2017 | 240 | 0.030 |
Why?
|
Greece | 1 | 1997 | 340 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3514 | 0.030 |
Why?
|
Algorithms | 3 | 2012 | 14018 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 1932 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 550 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14591 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12116 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2291 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11069 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15251 | 0.030 |
Why?
|
Growth | 1 | 1997 | 365 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 80566 | 0.030 |
Why?
|
Cell Movement | 2 | 2017 | 5200 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2022 | 4947 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1608 | 0.030 |
Why?
|
Sacrum | 1 | 2015 | 274 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14648 | 0.030 |
Why?
|
Neoplasms, Basal Cell | 1 | 2013 | 31 | 0.030 |
Why?
|
Down-Regulation | 2 | 2014 | 2915 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 6474 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8516 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2015 | 13635 | 0.030 |
Why?
|
Testosterone | 1 | 2003 | 2472 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10175 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4308 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2005 | 3356 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2017 | 908 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2009 | 11514 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9461 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2447 | 0.020 |
Why?
|
Reference Values | 2 | 2009 | 4919 | 0.020 |
Why?
|
Exonucleases | 1 | 2010 | 44 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4910 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2955 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2010 | 70 | 0.020 |
Why?
|
Pilot Projects | 1 | 2003 | 8618 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9586 | 0.020 |
Why?
|
Platinum Compounds | 1 | 2010 | 95 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 571 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2011 | 407 | 0.020 |
Why?
|
Lower Extremity | 1 | 2017 | 1200 | 0.020 |
Why?
|
Stem Cells | 1 | 2022 | 3516 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 294 | 0.020 |
Why?
|
Epigenomics | 1 | 2015 | 942 | 0.020 |
Why?
|
Retinal Dehydrogenase | 1 | 2009 | 78 | 0.020 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2009 | 146 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8699 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10432 | 0.020 |
Why?
|
Cystatins | 1 | 2008 | 55 | 0.020 |
Why?
|
Carboplatin | 1 | 2011 | 793 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2011 | 982 | 0.020 |
Why?
|
Mutation | 2 | 2010 | 30016 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2011 | 617 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2008 | 222 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6338 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 2008 | 238 | 0.020 |
Why?
|
Risk Factors | 2 | 2011 | 74115 | 0.020 |
Why?
|
Cystatin C | 1 | 2008 | 270 | 0.020 |
Why?
|
Clone Cells | 1 | 2010 | 1657 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2010 | 1349 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2015 | 1874 | 0.020 |
Why?
|
Mucin-1 | 1 | 2010 | 538 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2689 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.010 |
Why?
|
Isoenzymes | 1 | 2009 | 1687 | 0.010 |
Why?
|
Risk Assessment | 1 | 2004 | 23972 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4110 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2830 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2849 | 0.010 |
Why?
|
Cancer Vaccines | 1 | 2010 | 1037 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3419 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3145 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 974 | 0.010 |
Why?
|
Creatinine | 1 | 2007 | 1896 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2409 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6126 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9476 | 0.010 |
Why?
|
Fetal Blood | 1 | 2007 | 1347 | 0.010 |
Why?
|
Lasers | 1 | 2005 | 952 | 0.010 |
Why?
|
India | 1 | 2007 | 2286 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4739 | 0.010 |
Why?
|
Postmenopause | 1 | 2008 | 2511 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5463 | 0.010 |
Why?
|
Body Mass Index | 1 | 1997 | 12943 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6074 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4117 | 0.010 |
Why?
|
Blood Pressure | 1 | 2007 | 8472 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18381 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 13495 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2007 | 26180 | 0.000 |
Why?
|
Time Factors | 1 | 2007 | 39913 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2007 | 12142 | 0.000 |
Why?
|
United States | 1 | 2008 | 72272 | 0.000 |
Why?
|